Effect of etanercept plus lamivudine in a patient with rheumatoid arthritis and viral hepatitis B

被引：24

作者：

Benucci, Maurizio ^{[1
]}

Manfredi, Mariangela ^{[2
]}

Mecocci, Lorenzo ^{[3
]}

机构：

[1] Nuovo Osped S Giovanni Di Dio, Rheumatol Unit, Florence, Italy

[2] Nuovo Osped S Giovanni Di Dio, Immunnol & Allergol Lab Unit, Florence, Italy

[3] S Maria Annunziata Hosp, Infect Dis Unit, Florence, Italy

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2008年 / 14卷 / 04期

关键词：

D O I：

10.1097/RHU.0b013e318181b89d

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：245 / 246

页数：2

共 12 条

[1] Problems encountered during anti-tumour necrosis factor therapy [J].

Desai, Sheetal B. ;

Furst, Daniel E. .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (04) :757-790

[2] Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis [J].

Esteve, M ;

Saro, C ;

González-Huix, F ;

Suarez, F ;

Forné, M ;

Viver, JM .

GUT, 2004, 53 (09) :1363-1365

[3] A new hypothesis of pathogenetic mechanism of viral hepatitis B and C [J].

Liu, DX .

MEDICAL HYPOTHESES, 2001, 56 (03) :405-408

[4] A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis [J].

Menon, KVN ;

Stadheim, L ;

Kamath, PS ;

Wiesner, RH ;

Gores, GJ ;

Peine, CJ ;

Shah, V .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02) :255-260

[5]

Michel M, 2003, J RHEUMATOL, V30, P1624

[6] Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis [J].

Mookerjee, RP ;

Sen, S ;

Davies, NA ;

Hodges, SJ ;

Williams, R ;

Jalan, R .

GUT, 2003, 52 (08) :1182-1187

[7] A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis [J].

Naveau, S ;

Chollet-Martin, S ;

Dharancy, S ;

Mathurin, P ;

Jouet, P ;

Piquet, MA ;

Davion, T ;

Oberti, F ;

Broët, P ;

Emilie, D .

HEPATOLOGY, 2004, 39 (05) :1390-1397

[8]

Oniankitan O, 2004, J RHEUMATOL, V31, P107

[9] An overview of the immune system [J].

Parkin, J ;

Cohen, B .

LANCET, 2001, 357 (9270) :1777-1789

[10] Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis [J].

Roux, C. H. ;

Brocq, O. ;

Breuil, V. ;

Albert, C. ;

Euller-Ziegler, L. .

RHEUMATOLOGY, 2006, 45 (10) :1294-1297

← 1 2 →